Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Anthony Mato: LOXO-305 Demonstrates Efficacy in Patients With CLL/SLL

December 30, 2021

Anthony Mato, MD, shares findings from a phase I/II trial evaluating LOXO-305 in patients with heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
November 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals